Literature DB >> 24218628

No association between exposure to perfluorinated compounds and congenital cryptorchidism: a nested case-control study among 215 boys from Denmark and Finland.

Dorte Vesterholm Jensen1, Jeppe Christensen, Helena E Virtanen, Niels E Skakkebæk, Katharina M Main, Jorma Toppari, Christine W Veje, Anna-Maria Andersson, Flemming Nielsen, Philippe Grandjean, Tina Kold Jensen.   

Abstract

Geographical differences in the occurrence of diseases in male reproductive organs, including malformation in reproductive tract, between Denmark and Finland have been reported. The reason for these differences is unknown, but differences in exposure to chemicals with endocrine-disrupting abilities have been suggested. Among these chemicals are perfluoro-alkylated substances (PFASs), a group of water- and grease-repellent chemicals used in outdoor clothes, cookware, food packaging, and textiles. In this study, we, therefore, investigated differences in PFAS exposure levels between Denmark and Finland and the association between cord blood PFAS levels and congenital cryptorchidism. Boys from a joint ongoing prospective birth cohort study were included. We analyzed PFAS levels in cord blood serum samples collected from 29 Danish boys with congenital cryptorchidism, 30 healthy Danish matched controls recruited from 1997 to 2001, 30 Finnish cases, and 78 Finnish healthy matched controls recruited from 1997 to 1999. Additionally, 48 Finnish cases recruited from 2000 to 2002 were included. Perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) were detected in all the 215 Danish and Finnish cord blood samples with significantly higher levels being observed in the Danish samples (medians: PFOA, 2.6 ng/ml and PFOS, 9.1 ng/ml) than in the Finnish samples (medians: PFOA, 2.1 ng/ml and PFOS, 5.2 ng/ml). We found no associations between cord blood PFOA and PFOS levels and congenital cryptorchidism after adjustment for confounders. Our data indicate that women in Denmark and Finland are generally exposed to PFOA and PFOS but there are differences in exposure levels between countries. We found no statistically significant association between cord blood PFOA and PFOS levels and congenital cryptorchidism; however, our study was small and larger studies are warranted.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24218628     DOI: 10.1530/REP-13-0444

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  10 in total

Review 1.  Risk factors for cryptorchidism.

Authors:  Jason K Gurney; Katherine A McGlynn; James Stanley; Tony Merriman; Virginia Signal; Caroline Shaw; Richard Edwards; Lorenzo Richiardi; John Hutson; Diana Sarfati
Journal:  Nat Rev Urol       Date:  2017-06-27       Impact factor: 14.432

2.  Perfluoroalkyl substances with isomer analysis in umbilical cord serum in China.

Authors:  Ya-Zhi Zhang; Xiao-Wen Zeng; Zhengmin Min Qian; Michael G Vaughn; Sarah Dee Geiger; Li-Wen Hu; Long Lu; Chuanxi Fu; Guang-Hui Dong
Journal:  Environ Sci Pollut Res Int       Date:  2017-04-09       Impact factor: 4.223

Review 3.  Review of the environmental prenatal exposome and its relationship to maternal and fetal health.

Authors:  Julia E Rager; Jacqueline Bangma; Celeste Carberry; Alex Chao; Jarod Grossman; Kun Lu; Tracy A Manuck; Jon R Sobus; John Szilagyi; Rebecca C Fry
Journal:  Reprod Toxicol       Date:  2020-02-23       Impact factor: 3.143

Review 4.  EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Authors:  A C Gore; V A Chappell; S E Fenton; J A Flaws; A Nadal; G S Prins; J Toppari; R T Zoeller
Journal:  Endocr Rev       Date:  2015-11-06       Impact factor: 19.871

5.  Perfluorooctane Sulfonate Concentrations in Amniotic Fluid, Biomarkers of Fetal Leydig Cell Function, and Cryptorchidism and Hypospadias in Danish Boys (1980-1996).

Authors:  Gunnar Toft; Bo A G Jönsson; Jens Peter Bonde; Bent Nørgaard-Pedersen; David M Hougaard; Arieh Cohen; Christian H Lindh; Richard Ivell; Ravinder Anand-Ivell; Morten S Lindhard
Journal:  Environ Health Perspect       Date:  2015-06-05       Impact factor: 9.031

Review 6.  Environmental Endocrine-Disrupting Chemical Exposure: Role in Non-Communicable Diseases.

Authors:  Manoj Kumar; Devojit Kumar Sarma; Swasti Shubham; Manoj Kumawat; Vinod Verma; Anil Prakash; Rajnarayan Tiwari
Journal:  Front Public Health       Date:  2020-09-24

7.  Maternal Exposure to Per- and Polyfluoroalkyl Substances (PFAS) and Male Reproductive Function in Young Adulthood: Combined Exposure to Seven PFAS.

Authors:  Katia Keglberg Hærvig; Kajsa Ugelvig Petersen; Karin Sørig Hougaard; Christian Lindh; Cecilia Høst Ramlau-Hansen; Gunnar Toft; Aleksander Giwercman; Birgit Bjerre Høyer; Esben Meulengracht Flachs; Jens Peter Bonde; Sandra Søgaard Tøttenborg
Journal:  Environ Health Perspect       Date:  2022-10-05       Impact factor: 11.035

Review 8.  The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis.

Authors:  Jens Peter Bonde; Esben Meulengracht Flachs; Susie Rimborg; Clara Helene Glazer; Aleksander Giwercman; Cecilia Høst Ramlau-Hansen; Karin Sørig Hougaard; Birgit Bjerre Høyer; Katia Keglberg Hærvig; Sesilje Bondo Petersen; Lars Rylander; Ina Olmer Specht; Gunnar Toft; Elvira Vaclavik Bräuner
Journal:  Hum Reprod Update       Date:  2016-09-21       Impact factor: 15.610

Review 9.  Endocrine Disrupting Chemicals Interfere With Leydig Cell Hormone Pathways During Testicular Descent in Idiopathic Cryptorchidism.

Authors:  Patrick Fénichel; Nicolas Chevalier; Najiba Lahlou; Patrick Coquillard; Kathy Wagner-Mahler; Michel Pugeat; Patricia Panaïa-Ferrari; Françoise Brucker-Davis
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-10       Impact factor: 5.555

Review 10.  Endocrine Disrupting Chemicals and Reproductive Health in Boys and Men.

Authors:  Wiwat Rodprasert; Jorma Toppari; Helena E Virtanen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-07       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.